Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of Sodium Pentaborate on Left-Sided Ulcerative Colitis
IRCT20190701044062N11Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Aug 2022
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of sodium pentaborate pentahydrate in autoimmune colitis, sponsored by Tabriz University of Medical Sciences. Started Aug 2022; status: completed.
02
Drugs
sodium pentaborate pentahydrate
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on IRCT20190701044062N11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190701044062N11.